Hikma launches Ifosfamide injection

West-Ward Pharmaceuticals, wholly-owned  Hikma Pharmaceuticals’s US subsidiary has launched Ifosfamide Injection, 1g/20mL vials, the generic equivalent to Ifex.

West-Ward’s Ifosfamide Injection is indicated for use in combination with certain other approved antineoplastic agents for third-line chemotherapy of germ cell testicular cancer.  It should be used in combination with mesna for prophylaxis of hemorrhagic cystitis, the company noted.

According to IMS Health, US sales of Ifosfamide Injection, 1g/20mL vials, were approximately $0.6 million in the 12 months ending October 2017.